Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
TCR modulator
DRUG CLASS:
TCR modulator
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
afamitresgene autoleucel (3)
TAEST16001 (2)
ADP-A2M10 (1)
AFNT-211 (1)
BSB-1001 (1)
IMC-C103C (1)
GSK3377794 (1)
TBI-1301 (1)
ADP-A2AFP (0)
E6 TCR (0)
E7 TCR-T (0)
FH-TCR-Tᴍsʟɴ (0)
HA-1 T TCR T Cell Immunotherapy (0)
HRYZ-T101 (0)
IMA101 (0)
IMA201 (0)
IMA203CD8 (0)
IMA401 (0)
IMA402 (0)
KIND T (0)
KITE-718 (0)
LYL132 (0)
LYL331 (0)
LioCyx-M (0)
MAGE A3 TCR (0)
MCC1 TCR (0)
N201 (0)
NT-175 (0)
NY-ESO-1 TCR (0)
NY-ESO-1 TCR-T cell therapy (0)
NeoTCR-P1 (0)
SAR444200 (0)
SCG101 (0)
T-Plex-200-A0201/204-A0201 (0)
T-cell receptor therapy (0)
TBI 1201 (0)
TSC-100 (0)
TSC-101 (0)
TSC-200-A0201 (0)
TSC-204-A0201 (0)
TSC-204-C0702 (0)
YK0901 (0)
mono TRuC-T CD70 cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
afamitresgene autoleucel (3)
TAEST16001 (2)
ADP-A2M10 (1)
AFNT-211 (1)
BSB-1001 (1)
IMC-C103C (1)
GSK3377794 (1)
TBI-1301 (1)
ADP-A2AFP (0)
E6 TCR (0)
E7 TCR-T (0)
FH-TCR-Tᴍsʟɴ (0)
HA-1 T TCR T Cell Immunotherapy (0)
HRYZ-T101 (0)
IMA101 (0)
IMA201 (0)
IMA203CD8 (0)
IMA401 (0)
IMA402 (0)
KIND T (0)
KITE-718 (0)
LYL132 (0)
LYL331 (0)
LioCyx-M (0)
MAGE A3 TCR (0)
MCC1 TCR (0)
N201 (0)
NT-175 (0)
NY-ESO-1 TCR (0)
NY-ESO-1 TCR-T cell therapy (0)
NeoTCR-P1 (0)
SAR444200 (0)
SCG101 (0)
T-Plex-200-A0201/204-A0201 (0)
T-cell receptor therapy (0)
TBI 1201 (0)
TSC-100 (0)
TSC-101 (0)
TSC-200-A0201 (0)
TSC-204-A0201 (0)
TSC-204-C0702 (0)
YK0901 (0)
mono TRuC-T CD70 cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
›
Associations
(11)
News
Trials
VERI cancer hierarchy
Reset Filters
MAGEA4 expression
Synovial Sarcoma
MAGEA4 expression
Synovial Sarcoma
afamitresgene autoleucel
Sensitive: A1 - Approval
afamitresgene autoleucel
Sensitive
:
A1
afamitresgene autoleucel
Sensitive: A1 - Approval
afamitresgene autoleucel
Sensitive
:
A1
HLA-A*02:01
Soft Tissue Sarcoma
HLA-A*02:01
Soft Tissue Sarcoma
TAEST16001
Sensitive: C2 – Inclusion Criteria
TAEST16001
Sensitive
:
C2
TAEST16001
Sensitive: C2 – Inclusion Criteria
TAEST16001
Sensitive
:
C2
KRAS G12V
Solid Tumor
KRAS G12V
Solid Tumor
AFNT-211
Sensitive: C2 – Inclusion Criteria
AFNT-211
Sensitive
:
C2
AFNT-211
Sensitive: C2 – Inclusion Criteria
AFNT-211
Sensitive
:
C2
CTAG1B expression
Synovial Sarcoma
CTAG1B expression
Synovial Sarcoma
TBI-1301
Sensitive: C2 – Inclusion Criteria
TBI-1301
Sensitive
:
C2
TBI-1301
Sensitive: C2 – Inclusion Criteria
TBI-1301
Sensitive
:
C2
HLA-A*02 + MAGEA10 expression
Non Small Cell Lung Cancer
HLA-A*02 + MAGEA10 expression
Non Small Cell Lung Cancer
ADP-A2M10
Sensitive: C3 – Early Trials
ADP-A2M10
Sensitive
:
C3
ADP-A2M10
Sensitive: C3 – Early Trials
ADP-A2M10
Sensitive
:
C3
HLA-A*02 + MAGEA4 expression
Soft Tissue Sarcoma
HLA-A*02 + MAGEA4 expression
Soft Tissue Sarcoma
afamitresgene autoleucel
Sensitive: C3 – Early Trials
afamitresgene autoleucel
Sensitive
:
C3
afamitresgene autoleucel
Sensitive: C3 – Early Trials
afamitresgene autoleucel
Sensitive
:
C3
HLA-A*02 + MAGEA4 expression
Ovarian Cancer
HLA-A*02 + MAGEA4 expression
Ovarian Cancer
IMC-C103C
Sensitive: C3 – Early Trials
IMC-C103C
Sensitive
:
C3
IMC-C103C
Sensitive: C3 – Early Trials
IMC-C103C
Sensitive
:
C3
HLA-A*02:01 + MAGEA4 expression
Synovial Sarcoma
HLA-A*02:01 + MAGEA4 expression
Synovial Sarcoma
afamitresgene autoleucel
Sensitive: C3 – Early Trials
afamitresgene autoleucel
Sensitive
:
C3
afamitresgene autoleucel
Sensitive: C3 – Early Trials
afamitresgene autoleucel
Sensitive
:
C3
HLA-A*02:01 + CTAG1B expression
Soft Tissue Sarcoma
HLA-A*02:01 + CTAG1B expression
Soft Tissue Sarcoma
TAEST16001
Sensitive: C3 – Early Trials
TAEST16001
Sensitive
:
C3
TAEST16001
Sensitive: C3 – Early Trials
TAEST16001
Sensitive
:
C3
CTAG1B expression + CTAG2 expression
Non Small Cell Lung Cancer
CTAG1B expression + CTAG2 expression
Non Small Cell Lung Cancer
GSK3377794
Sensitive: D – Preclinical
GSK3377794
Sensitive
:
D
GSK3377794
Sensitive: D – Preclinical
GSK3377794
Sensitive
:
D
HLA-A*02:01
Acute Myelogenous Leukemia
HLA-A*02:01
Acute Myelogenous Leukemia
BSB-1001
Sensitive: D – Preclinical
BSB-1001
Sensitive
:
D
BSB-1001
Sensitive: D – Preclinical
BSB-1001
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login